Trials / Unknown
UnknownNCT02400866
A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 58 (estimated)
- Sponsor
- Korean South West Oncology Group · Network
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This aim of study is to evaluate the safety and efficacy of olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy by a randomized, double-blind, placebo-controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olanzapine |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2015-11-01
- Completion
- 2017-04-01
- First posted
- 2015-03-27
- Last updated
- 2015-03-27
Source: ClinicalTrials.gov record NCT02400866. Inclusion in this directory is not an endorsement.